US Stock MarketDetailed Quotes

PLSE Pulse Biosciences

Watchlist
  • 16.060
  • -0.150-0.93%
Close Mar 21 16:00 ET
  • 16.200
  • +0.140+0.87%
Post 20:01 ET
987.96MMarket Cap-19.12P/E (TTM)

About Pulse Biosciences Company

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.

Company Profile

SymbolPLSE
Company NamePulse Biosciences
Listing DateMay 18, 2016
Issue Price4.00
Founded2014
CEOMr. Paul A. Laviolette
MarketNASDAQ
Employees56
Fiscal Year Ends12-31
Address3957 Point Eden Way
CityHayward
ProvinceCalifornia
CountryUnited States of America
Zip Code94545
Phone1-510-906-4600
Websitehttp://www.pulsebiosciences.com

Company Executives

  • Name
  • Position
  • Salary
  • Paul A. Laviolette
  • Co-Chairman of the Board, Chief Executive Officer and President
  • --
  • Mitchell E. Levinson
  • Chief Strategy Officer
  • 1.69M
  • Jon Skinner
  • Chief Financial Officer
  • --
  • Kevin P. Danahy
  • Chief Commercial Officer
  • 5.86M
  • Darrin R. Uecker
  • Chief Technology Officer and Director
  • 5.39M
  • Timothy H. Mitsuoka
  • Corporate Controller and Principal Accounting Officer
  • --
  • Robert W. Duggan
  • Co-Chairman of the Board
  • 257.41K
  • Dr. Mahkam Zanganeh
  • Independent Director
  • 173.00K
  • Shelley D. Spray
  • Independent Director
  • 123.47K
  • Manmeet Singh Soni
  • Lead Independent Director
  • 180.07K
  • Richard A. van den Broek
  • Independent Director
  • 208.89K

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Tesla
TSLA
248.710
Apple
AAPL
218.270
Meta Platforms
META
596.250
4
Microsoft
MSFT
391.260
5
Petroleo Brasileiro SA Petrobras
PBR
14.160
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings